PURPOSE: Previous studies have suggested that higher levels of physical activity may lower lung cancer risk; however, few prospective studies have evaluated lung cancer mortality in relation to cardiorespiratory fitness (CRF), an objective marker of recent physical activity habits. METHODS: Thirty-eight thousand men, aged 20-84 yr, without history of cancer, received a preventive medical examination at the Cooper Clinic in Dallas, Texas, between 1974 and 2002. CRF was quantified as maximal treadmill exercise test duration and was grouped for analysis as low (lowest 20% of exercise duration), moderate (middle 40%), and high (upper 40%). RESULTS: A total of 232 lung cancer deaths occurred during follow-up (mean = 17 yr). After adjustment for age, examination year, body mass index, smoking, drinking, physical activity, and family history of cancer, hazard ratios (95% confidence intervals) for lung cancer deaths across low, moderate, and high CRF categories were 1.0, 0.48 (0.35-0.67), and 0.43 (0.28-0.65), respectively. There was an inverse association between CRF and lung cancer mortality in former (P for trend = 0.005) and current smokers (P for trend < 0.001) but not in never smokers (trend P = 0.14). Joint analysis of smoking and fitness status revealed a significant 12-fold higher risk of death in current smokers (hazard ratio = 11.9, 95% confidence interval = 6.0-23.6) with low CRF as compared with never smokers who had high CRF. CONCLUSIONS: Although the potential for some residual confounding by smoking could not be eliminated, these data suggest that CRF is inversely associated with lung cancer mortality in men. Continued study of CRF in relation to lung cancer, particularly among smokers, may further our understanding of disease etiology and reveal additional strategies for reducing its burden.
PURPOSE: Previous studies have suggested that higher levels of physical activity may lower lung cancer risk; however, few prospective studies have evaluated lung cancer mortality in relation to cardiorespiratory fitness (CRF), an objective marker of recent physical activity habits. METHODS: Thirty-eight thousand men, aged 20-84 yr, without history of cancer, received a preventive medical examination at the Cooper Clinic in Dallas, Texas, between 1974 and 2002. CRF was quantified as maximal treadmill exercise test duration and was grouped for analysis as low (lowest 20% of exercise duration), moderate (middle 40%), and high (upper 40%). RESULTS: A total of 232 lung cancer deaths occurred during follow-up (mean = 17 yr). After adjustment for age, examination year, body mass index, smoking, drinking, physical activity, and family history of cancer, hazard ratios (95% confidence intervals) for lung cancer deaths across low, moderate, and high CRF categories were 1.0, 0.48 (0.35-0.67), and 0.43 (0.28-0.65), respectively. There was an inverse association between CRF and lung cancer mortality in former (P for trend = 0.005) and current smokers (P for trend < 0.001) but not in never smokers (trend P = 0.14). Joint analysis of smoking and fitness status revealed a significant 12-fold higher risk of death in current smokers (hazard ratio = 11.9, 95% confidence interval = 6.0-23.6) with low CRF as compared with never smokers who had high CRF. CONCLUSIONS: Although the potential for some residual confounding by smoking could not be eliminated, these data suggest that CRF is inversely associated with lung cancer mortality in men. Continued study of CRF in relation to lung cancer, particularly among smokers, may further our understanding of disease etiology and reveal additional strategies for reducing its burden.
Authors: Adonina Tardon; Won Jin Lee; Miguel Delgado-Rodriguez; Mustafa Dosemeci; Demetrius Albanes; Robert Hoover; Aaron Blair Journal: Cancer Causes Control Date: 2005-05 Impact factor: 2.506
Authors: Catherine M Alfano; Robert C Klesges; David M Murray; Deborah J Bowen; Anne McTiernan; Mark W Vander Weg; Leslie A Robinson; Brenda Cartmel; Mark D Thornquist; Matt Barnett; Gary E Goodman; Gilbert S Omenn Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-12 Impact factor: 4.254
Authors: Peter Schnohr; Morten Grønbaek; Liselotte Petersen; Hans Ole Hein; Thorkild I A Sørensen Journal: Scand J Public Health Date: 2005 Impact factor: 3.021
Authors: Helle Bak; Jane Christensen; Birthe Lykke Thomsen; Anne Tjønneland; Kim Overvad; Steffen Loft; Ole Raaschou-Nielsen Journal: Int J Cancer Date: 2005-09-01 Impact factor: 7.396
Authors: Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West Journal: J Clin Oncol Date: 2007-02-10 Impact factor: 44.544
Authors: Karen Steindorf; Christine Friedenreich; Jakob Linseisen; Sabine Rohrmann; Andrew Rundle; Fabrizio Veglia; Paolo Vineis; Nina Fønns Johnsen; Anne Tjønneland; Kim Overvad; Ole Raaschou-Nielsen; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Mandy Schulz; Heiner Boeing; Antonia Trichopoulou; Victoria Kalapothaki; Maria Koliva; Vittorio Krogh; Domenico Palli; Rosario Tumino; Salvatore Panico; Evelyn Monninkhof; Petra H Peeters; Hendriek C Boshuizen; H Bas Bueno-de-Mesquita; Maria-Dolores Chirlaque; Antonio Agudo; Nerea Larrañaga; José R Quirós; Carmen Martínez; Aurelio Barricarte; Lars Janzon; Göran Berglund; Sheila Bingham; Kay-Tee Khaw; Timothy J Key; Teresa Norat; Mazda Jenab; Anne Cust; Elio Riboli Journal: Int J Cancer Date: 2006-11-15 Impact factor: 7.396
Authors: Ange Wang; FeiFei Qin; Haley Hedlin; Manisha Desai; Rowan Chlebowski; Scarlett Gomez; Charles B Eaton; Karen C Johnson; Lihong Qi; Jean Wactawski-Wende; Catherine Womack; Heather A Wakelee; Marcia L Stefanick Journal: Int J Cancer Date: 2016-11-15 Impact factor: 7.396
Authors: James R Hébert; Michael Wirth; Lisa Davis; Briana Davis; Brook E Harmon; Thomas G Hurley; Ruby Drayton; E Angela Murphy; Nitin Shivappa; Sara Wilcox; Swann A Adams; Heather M Brandt; Christine E Blake; Cheryl A Armstead; Susan E Steck; Steven N Blair Journal: Am J Prev Med Date: 2013-10 Impact factor: 5.043
Authors: Claude Bouchard; Ligia M Antunes-Correa; Euan A Ashley; Nina Franklin; Paul M Hwang; C Mikael Mattsson; Carlos E Negrao; Shane A Phillips; Mark A Sarzynski; Ping-Yuan Wang; Matthew T Wheeler Journal: Prog Cardiovasc Dis Date: 2014-08-13 Impact factor: 8.194